Vatan None Barışık

Dr. Vatan None Barışık

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 September 2021 in Journal of Medicine and Palliative Care
Verified
Journal Article
Closed access
PDF file
DADinçer Ati̇la
Dinçer Ati̇la
YÖYasemin KILIÇ ÖZTÜRK
Yasemin KILIÇ ÖZTÜRK
VBVatan None Barışık
Vatan None Barışık
EÇElif Okşan ÇALIKOĞLU
Elif Okşan ÇALIKOĞLU
Giriş: Bu çalışmada, İzmir Menemen 1 No’lu Aile Sağlığı Merkezine başvuran hipertansif hastaların hastalıkla ilgili bilgi ve tutumlarının araştırılması amaçlanmıştır. Gereç ve Yöntem: Tanımlayıcı-kesitsel tasarımdaki bu çalışma 24 Mart - 30 Ağustos 2021 tarihleri arasında Menemen 1 No’lu Aile Sağlığı Merkezi’nde yürütülmüştür. Hastaların sosyo-demografik verileri, kronik hastalık öykülerive hipertansiyon tanı ve tedavisiyle ilgili bilgi düzeyi ve tutumlarına yönelik sorular içeren anket formu yüzyüze görüşme tekniği ile uygulandı. Verilerin analizi SPSS 16.0 paket programıyla yapıldı. Bulgular: Katılımcıların 61 (%38,9)’i erkek, 96 (%61,1)’sı kadındı. Yaş ortalaması 60,73±11,24 (en küçük 34, en büyük 89) yıl idi. Katılımcıların çoğunluğu (%90,4) ilköğretim mezunuydu, 99 (%63,1) kişide kronik hastalık öyküsü saptandı, 39 (%24,8) kişi düzenli egzersiz yaptığını belirtti. Sonuç: Araştırmada katılımcıların hipertansiyonla ilgili bilgi düzeylerinin yeterli olmadığı saptandı. Hastalar hipertansiyon konusunda bilgilendirilmeli, düzenli doktor kontrolü ve ilaç kullanımı konusunda yönlendirilmelidir. Topluma yönelik eğitim projeleri planlanmalıdır.

4 September 2023 in Journal of Pediatric Endocrinology and Metabolism
Verified
Journal Article
Closed access
HKHuseyin Anıl Korkmaz
Huseyin Anıl Korkmaz
FCFulya Coşkunol
Fulya Coşkunol
VBVatan None Barışık
Vatan None Barışık
BOBehzat Ozkan
Behzat Ozkan
Objectives We aimed to assess the efficacy of oral use of OLD in children with CDI. Methods Clinical, laboratory, and imaging characteristics of twenty-five children with CDI treated with OLD were evaluated. Results Fourteen boys and eleven girls with a mean age of 52.37 months were evaluated. These children (mean weight and height at admission, 26.81 ± 14.8 kg vs. 92.52 ± 30 cm) presented with failure to thrive, irritability, prolonged fever, polyuria and hypernatremia (mean sodium level, 143.12 ± 8.6 mEq/L). At the time of hypernatremia, mean serum and urine osmolality were 298.2 ± 18 mOsm/kg and 160.20 ± 8.7 mOsm/kg, respectively. ADH levels were undetectable (<0.5 pmol/L) at admission in all cases. Oral administration of desmopressin lyophilisate (120 µg/tablet) was initiated at a dose of 5 μg/kg/day in two divided doses together with controlled water intake to avoid hyponatremia. Serum sodium levels normalised in a mean duration of 15.2 ± 16.4 h with a mean decline rate of 0.12 ± 0.04 mEq/L/h. Nine children needed rehospitalization because of hypernatremia due to non-compliance. Four episode of hyponatremia was observed. Weight gain and growth were normal during the mean follow-up duration of 37.79 ± 48.2 months. Conclusions Administration of OLD was practical and safe in the treatment of CDI in children with CNS malformations in this small retrospective series.

29 May 2023 in Family Practice and Palliative Care
Verified
Journal Article
Open access
PDF file
DADinçer Ati̇lA
Dinçer Ati̇lA
VBVatan None Barışık
Vatan None Barışık
Introduction: This study aimed to investigate the relationship between MPV and disease prognosis in patients with COVID-19, the chronic diseases that affect the prognosis of COVID-19, and the laboratory data that can help diagnose this disease and provide information about the course of the disease during the treatment process. Methods: The study was conducted in a cross-sectional format. All participants gave written, informed consent to participate. A questionnaire consisting of two parts, including categorical (socio-demographic) data and laboratory data, was applied to people who had COVID-19 who applied to the internal medicine outpatient clinic of the hospital. The Pearson chi-squared test and Fisher exact test were used for comparing categorical variables. The Mann-Whitney U test, or Kruskal-Wallis test with Bonferroni post hoc comparisons, was used to compare numerical variables between the groups. All analyses were performed using the SPSS 25.0 (SPSS Inc., Chicago, IL, ‎USA) software package. Results: The participants' mean (±SD) age was 40.8±13.7 years (median: 40, range: 18 – 72). Almost half of the participants (48.0%, n=98) were male, the majority (76.0%, n=155) were married, and 24.0% (n=49) were single. Of the 204 patients, 28 (13.7%) were hospitalized, and five died (2.5%). Of the five patients who died, three had chronic lung disease, one had diabetes and chronic lung disease, and one had no chronic disease. Conclusion: Older age and the presence of chronic diseases are important factors affecting hospitalization in patients with COVID-19. LDH, CRP, and ferritin levels were high, and the mean platelet volume levels were significantly higher in hospitalized patients. Keywords: COVID -19, pandemics, prognosis of COVID -19

5 November 2026 in Healthcare
Verified
Journal Article
Open access
PDF file
DADinçer Atila
Dinçer Atila
AYAkgün Yeşiltepe
Akgün Yeşiltepe
SBSemra Bulbuloglu
Semra Bulbuloglu
VBVatan None Barışık
Vatan None Barışık
Background: Eczema may affect not only dermatological health but also sexual well-being, treatment-related behaviors, and interpersonal relationships. Examining sexual function alongside medication-related factors and perceived spousal support may provide a broader understanding of women’s experiences of eczema. Methods: This cross-sectional study aimed to evaluate sexual dysfunction, medication adherence, and perceived spousal support and to examine the relationships among these factors in women with eczema. The study included 218 women diagnosed with eczema who were regularly followed in the dermatology unit of a private hospital in İzmir, Turkey. Data were collected using a personal information form, the Modified Morisky Adherence Scale (MMAS), the Spousal Support Scale (SS), and the Arizona Sexual Experiences Scale (ASEX). Descriptive statistics, Pearson correlations, Spearman sensitivity analyses, and three-step hierarchical multiple linear regression were performed. Results: All participants were using antihistamines, and 71.6% reported using them twice daily. According to the ASEX cutoff score, 59.2% of participants screened positive for potential sexual dysfunction, while 56.9% reported not receiving spousal support. The mean ASEX score was 16.19 ± 8.94, and the mean MMAS score was 2.53 ± 2.21. ASEX scores were moderately and positively correlated with MMAS scores (r = 0.528, p < 0.001), whereas the SS total score was not significantly correlated with ASEX (r = −0.026, p = 0.704). ASEX scores were found to be positively correlated with scores on both the motivation (r = 0.568; p < 0.001) and knowledge (r = 0.426; p < 0.001) subdimensions. In hierarchical regression, MMAS scores remained positively associated with ASEX scores after adjustment for age, menopausal status, chronic disease, and antihistamine use duration, although the association was considerably weaker (B = 0.700, p = 0.038); this model explained 51.4% of the variance. Adding sexual intercourse frequency increased the explained variance to 70.5%, and the MMAS association was no longer statistically significant (B = 0.316, p = 0.237). Conclusions: Sexual dysfunction was common in this sample of women with eczema. In bivariate analyses, higher scores for medication-related motivation and knowledge were associated with greater sexual dysfunction. The association between total MMAS and ASEX scores remained significant after adjustment for clinical factors; however, this association weakened and lost statistical significance when sexual intercourse frequency was included in the model. While these findings support the need to consider sexual health during clinical assessment, they do not establish a causal relationship between medication adherence and sexual functioning.